NEI
ALXN

Northwest & Ethical Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Northwest & Ethical Investments’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,540
Closed -$1.49M – 441
2020
Q4 		$1.49M Hold
9,540
– – 0.06% 288
2020
Q3 		$1.09M Sell
9,540
-403
-4% -$43.5K 0.05% 297
2020
Q2 		$1.12M Buy
+9,943
New +$1.06M 0.05% 293

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northwest & Ethical Investments's ALXN Position: Q1 2021 in Review

Northwest & Ethical Investments sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 9,540 shares — an estimated $1.49M sold.

Northwest & Ethical Investments first reported a position in ALXN in Q2 2020 and held it in 3 quarters. The position peaked at $1.49M in Q4 2020. 753 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Northwest & Ethical Investments reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Northwest & Ethical Investments sold 9,540 Alexion Pharmaceuticals shares in Q1 2021, an estimated $1.49M.
  • Northwest & Ethical Investments first reported a position in Alexion Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Northwest & Ethical Investments's Alexion Pharmaceuticals position peaked at $1.49M in Q4 2020.
  • 753 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Northwest & Ethical Investments's 13F filing for Q1 2021, filed 9 Jul 2025.